Funder: Alzheimer's Drug Discovery Foundation
Due Dates: September 14, 2026: Letter of Intent deadline (must be received by 5:00 pm ET)
Funding Amounts: Up to $5,000,000 per award for clinical trials; multi-year funding; direct costs only; milestone-based payments.
Summary: Funds human studies on precision prevention, combination therapies, and comparative effectiveness to reduce Alzheimer's and dementia risk, prioritizing drug-based interventions.
Key Information: Lifestyle-only and anti-amyloid approaches are not eligible; funding is structured as mission-related investment, not a traditional grant.